Abstract
Background: Depression is a robust predictor of nonadherence to antiretroviral (ARV) therapy, which is essential to prevention of mother-to-child transmission (PMTCT). Women in resource-limited settings face additional barriers to PMTCT adherence. Although structural barriers may be minimized by social support, depression and stigma may impede access to this support. Purpose: To better understand modifiable factors that contribute to PMTCT adherence and inform intervention development. Methods: We tested an ARV adherence model using data from 200 pregnant women enrolled in PMTCT (median age 28), who completed a third-trimester interview. Adherence scores were created using principal components analysis based on four questions assessing 30-day adherence. We used path analysis to assess (i) depression and stigma as predictors of social support and then (ii) the combined associations of depression, stigma, social support, and structural barriers with adherence. Results: Elevated depressive symptoms were directly associated with significantly lower adherence (est =-8.60, 95% confidence interval [-15.02,-2.18], p
Author supplied keywords
Cite
CITATION STYLE
Psaros, C., Smit, J. A., Mosery, N., Bennett, K., Coleman, J. N., Bangsberg, D. R., & Safren, S. A. (2020). PMTCT Adherence in Pregnant South African Women: The Role of Depression, Social Support, Stigma, and Structural Barriers to Care. Annals of Behavioral Medicine, 54(9), 626–636. https://doi.org/10.1093/abm/kaaa005
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.